Table 1.

Clinical data of patients who developed pancreatitis after OLTx

Case	Age/ Sex	POD# on Diagnosis	Cause	Highest Amylase (IU/l)	Clinical Presentation	Sequelae	Treatment	Outcome
1	37/M	2	IAG	1.764	PGNFN	none	OLTx IV	died of PGNFN
2	62/F	2	IAG	535	PGNFN	pancreatic abscesses (14)*	drainage, OLTx II	died of PGNFN
3	26/M	1	IAG	1.193	poor GFN, fever, hypocal- cemia	pseudocysts (32)*, in- fected pseudocysts (80*)	drainage	alive and well
4	43/F	2	IAG	7.121	poor GFN ARF, semicoma	retroperitoneal abscess (15)*	drainage	died of MOF
5	49/F	71	migrated T-tube	2.900	fever, back pain	none	removal of T-tube	alive and well
6	58/M	108	HBV	1.889	stupor, acute abdomen	none	NPO, NG suction IV fluid	died of MOF
7	31/M	41 (au- topsy)	CMV	1.072	systemic CMV infection	none		died of systemic CMV in- fection
8	65/F	56	unknown	(1.952)+	pancreatic pseudocysts	infected pseudocysts (62)*	drainage	alive and well

^{( )*}=number of postoperative day;

^{( )+}=data on the 3rd postoperative d;

OLTx=orthotopic liver transplantation; POD#=postoperative day; IAG=iliac artery graft PGNFN=primary graft non-function; GFN graft-function; ARF=acute renal failure; MOF=multiple organ failure; HBV=hepatitis B virus; CMV=cytomegalovirus.